Recylex SA
PAR:RX

Watchlist Manager
Recylex SA Logo
Recylex SA
PAR:RX
Watchlist
Price: 1.848 EUR 0.65% Market Closed
Market Cap: 47.8m EUR

Wall Street
Price Targets

RX Price Targets Summary
Recylex SA

There are no price targets for RX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Recylex SA Competitors:
Price Targets

Revenue
Forecast

-16% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-16% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Recylex SA's revenue is -16%. The projected CAGR for the next 8 years is 20%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
-34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
-34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Recylex SA's net income for the next 8 years is -34%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RX's stock price target?
Not Available

RX doesn't have any price targets made by Wall Street professionals.

What is Recylex SA's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Recylex SA's revenue is -16%. The projected CAGR for the next 8 years is 20%.

What is Recylex SA's Net Income forecast?
Projected CAGR
-34%

The compound annual growth rate of Recylex SA's net income for the next 8 years is -34%.

Back to Top